Veltist
The sealant that contains and detects GI leaks.
AnastoSEAL tackles gastrointestinal anastomotic leaks, affecting more than 1 in 10 patients among 14 million annual abdominal surgeries worldwide. Manifesting days post-surgery, these leaks cause delayed recoveries, soaring healthcare costs, and up to 33% mortality. Current solutions fail due to weak adhesion and lack of early detection. AnastoSEAL combines high-performance tissue adhesion with early leak detection using standard hospital imaging such as ultrasound and CT, replacing blind post-operative routine with confidence and clarity. Dr. Alexandre Anthis (CEO & founder) leads a team at Wyss Zurich combining product development experts with leading visceral surgeons. Addressing a $7B problem, AnastoSEAL aims to eliminate this deadly complication from care.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
No news
01.04.2026
No Jobs
Videos
Veltist featured on the Venturekick channel !
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Veltist
The sealant that contains and detects GI leaks.
Website:
veltist.com/
Headquarter:
Zurich
Technology:
- Medtech
Sectors:
- Biomaterials
- Digital Health
- Diagnostics
- Materials
- Imaging and Radiology
- Medical devices
- Medtech
- Research and development
- Organ and Tissues
- Patient monitoring
- Surgery
- Wound management
Support received
